VASAPOLLO, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 9.355
AS - Asia 2.253
EU - Europa 1.859
SA - Sud America 347
Continente sconosciuto - Info sul continente non disponibili 271
AF - Africa 39
OC - Oceania 9
AN - Antartide 1
Totale 14.134
Nazione #
US - Stati Uniti d'America 9.202
SG - Singapore 1.248
IT - Italia 722
CN - Cina 385
BR - Brasile 271
RU - Federazione Russa 240
VN - Vietnam 169
DE - Germania 146
HK - Hong Kong 127
IE - Irlanda 119
PL - Polonia 105
FR - Francia 99
GB - Regno Unito 82
FI - Finlandia 80
CA - Canada 78
UA - Ucraina 75
NL - Olanda 73
BD - Bangladesh 70
JP - Giappone 66
SE - Svezia 44
IN - India 36
ID - Indonesia 28
AR - Argentina 27
MX - Messico 25
KR - Corea 19
CZ - Repubblica Ceca 17
IQ - Iraq 17
ES - Italia 16
TR - Turchia 16
CR - Costa Rica 11
PK - Pakistan 11
JM - Giamaica 10
NP - Nepal 10
ZA - Sudafrica 10
AU - Australia 9
CO - Colombia 9
EC - Ecuador 9
GT - Guatemala 8
IL - Israele 8
VE - Venezuela 8
BE - Belgio 7
PE - Perù 7
CL - Cile 6
MY - Malesia 6
AT - Austria 5
BO - Bolivia 5
HN - Honduras 5
IR - Iran 5
MA - Marocco 5
SV - El Salvador 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
DZ - Algeria 4
HR - Croazia 4
KE - Kenya 4
RS - Serbia 4
SA - Arabia Saudita 4
SC - Seychelles 4
UZ - Uzbekistan 4
DK - Danimarca 3
HU - Ungheria 3
LT - Lituania 3
NI - Nicaragua 3
PR - Porto Rico 3
PY - Paraguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
JO - Giordania 2
LV - Lettonia 2
PS - Palestinian Territory 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AQ - Antartide 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GI - Gibilterra 1
GP - Guadalupe 1
GR - Grecia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LK - Sri Lanka 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
PT - Portogallo 1
Totale 13.862
Città #
Woodbridge 1.699
Wilmington 1.681
Houston 1.530
Singapore 469
Ashburn 455
San Jose 348
Fairfield 240
Council Bluffs 197
Chandler 184
Ann Arbor 159
Rome 152
Hong Kong 120
Dublin 116
Beijing 114
New York 107
Los Angeles 100
Kraków 93
Seattle 93
Cambridge 87
Santa Clara 78
The Dalles 63
Medford 62
Milan 61
Ho Chi Minh City 60
Helsinki 56
Tokyo 54
Jacksonville 53
Zhengzhou 52
Dearborn 50
Dallas 47
North Bergen 44
Hanoi 42
Boardman 39
Cedarhurst 33
São Paulo 32
Chicago 31
Moscow 30
Buffalo 29
Lawrence 28
Denver 26
Lauterbourg 25
Atlanta 22
Phoenix 22
Naples 21
Redondo Beach 21
Montreal 19
Florence 18
Monte Vista 18
Washington 18
San Diego 17
Columbus 16
Frankfurt am Main 16
Amsterdam 15
Olomouc 15
Palermo 15
Bologna 13
Boston 13
Shanghai 13
San Francisco 12
Toronto 12
Utrecht 12
Vancouver 12
Brooklyn 11
Dhaka 11
Munich 11
Chennai 10
Genoa 10
Las Vegas 10
London 10
Orem 10
Salt Lake City 10
Stockholm 10
Turin 10
Rio de Janeiro 9
Tampa 9
Ascoli Piceno 8
Lappeenranta 8
Manchester 8
Melbourne 8
Mülheim 8
Baghdad 7
Brussels 7
Guangzhou 7
Poplar 7
Redwood City 7
San José 7
Venice 7
Warsaw 7
Ankara 6
Augusta 6
Belo Horizonte 6
Charlotte 6
City of London 6
Johannesburg 6
Mexico City 6
Norfolk 6
Pescara 6
Quito 6
Suzhou 6
Treviso 6
Totale 9.578
Nome #
Body composition during normal pregnancy: reference ranges 689
Medical treatment of early-onset mild gestational hypertension reduces total peripheral vascular resistance and influences maternal and fetal complications 576
Are Gestational and Essential Hypertension Similar? Left Ventricular Geometry and Diastolic Function 557
Abnormal maternal cardiac function precedes the clinical manifestation of fetal growth restriction 523
Fetal subcutaneous tissue thickness (SCTT) in healthy and gestational diabetic pregnancies 521
Left ventricular midwall mechanics at 24 weeks' gestation in high-risk normotensive pregnant women: Relationship to placenta-related complications of pregnancy 499
Assessment of total vascular resistance and total body water in normotensive women during the first trimester of pregnancy. A key for the prevention of preeclampsia 498
Maternal total vascular resistance and concentric geometry: A key to identify uncomplicated gestational hypertension 447
Maternal and fetal hemodynamic effects induced by nitric oxide donors and plasma volume expansion in pregnancies with gestational hypertension complicated by intrauterine growth restriction with absent end-diastolic flow in the umbilical artery 447
The computerized fetal heart rate analysis in post-term pregnancy identifies patients at risk for fetal distress in labour 429
Nifedipine-induced changes in body composition in hypertensive patients at term 410
Screening for pre-eclampsia in the first trimester: role of maternal hemodynamics and bioimpedance in non-obese patients 408
Maternal body composition at term gestation and birth weight: is there a link? 376
Total body water estimation and maternal cardiac systolic function assessment in normal and gestational hypertensive pregnant women 373
Maternal cardiac systolic function and total body water estimation in normal and gestational hypertensive women 364
Foetal heart rate deceleration with combined spinal-epidural analgesia during labour: A maternal haemodynamic cardiac study 300
Maternal Hemodynamics from Preconception to Delivery: Research and Potential Diagnostic and Therapeutic Implications: Position Statement by Italian Association of Pre-Eclampsia and Italian Society of Perinatal Medicine 281
Early and Late preeclampsia: Two different maternal hemodynamic states in the latent phase of the disease 238
Correlation between maternal body composition and haemodynamic changes in pregnancy: different profiles for different hypertensive disorders 218
Maternal hemodynamics early in labor: a possible link with obstetric risk? 209
Fetal growth restriction and maternal cardiac function 195
Hemodynamic guided treatment of hypertensive disorders in pregnancy: is it time to change our mind? 187
Methods and considerations concerning cardiac output measurement in pregnant women: recommendations of the International Working Group on Maternal Hemodynamics 178
Restricted physical activity in pregnancy reduces maternal vascular resistance and improves fetal growth 174
Pregnancy complications in chronic hypertensive patients are linked to pre-pregnancy maternal cardiac function and structure 170
Preterm delivery and elevated maternal total vascular resistance: signs of suboptimal cardiovascular adaptation to pregnancy? 170
Friendly help for clinical use of maternal hemodynamics 168
Persistent maternal cardiac dysfunction after preeclampsia identifies patients at risk for recurrent preeclampsia 159
Hemodynamic Prediction and Stratification of Hypertensive Disorders of Pregnancy: A Dream That Is Coming True? 158
Effect of a nitric oxide donor on maternal hemodynamics in fetal growth restriction 155
Distinction between SGA and FGR by means of fetal umbilical vein flow and maternal hemodynamics 149
The “Preeclampsia and Hypertension Target Treatment” (“PYTT”) study: a multicenter prospective study to evaluate the effectiveness of the antihypertensive therapy based on maternal hemodynamic findings 146
Prenatal and postnatal imaging of multiple intracranial lipomas: Report of a Case 130
Systemic vascular resistance may influence the outcome of in vitro fertilization 126
Are Chlamydia Trachomatis and Neisseria Gonorrhoeae Screenings in Pregnant Women Being Properly Performed? A Single-Center Retrospective Observational Study in Italy 120
Cardiac Function 119
Fetal Umbilical Vein Flow in the Classification of Fetuses with Growth Restriction 117
Hemodynamic maladaptation and left ventricular dysfunction in chronic hypertensive patients at the beginning of gestation and pregnancy complications: a case control study 116
Abnormal maternal cardiac function and morphology in pregnancies complicated by intrauterine fetal growth restriction 116
Maternal cardiovascular profile is altered in the preclinical phase of normotensive early and late intrauterine growth restriction 110
Maternal peripheral vascular resistance at mid gestation in chronic hypertension as a predictor of fetal growth restriction 108
D2. Screening of preeclampsia (PE) in the first trimester: high total vascular resistance (TVR) with a reduced fat mass increase the risk in normo BMI patients 105
G2. Low pregestational fat mass and subsequent maternal cardiovascular maladaptation in early pregnancy. The missing link for preeclampsia 104
Definition, identification, implications and management of hypodynamic hypertension in pregnancy 103
Restricted physical activity and maternal rest improve fetal growth: should we look for the reason in the cardiovascular modifications? 103
F1. Is there a correlation between total body water distribution and haemodynamic changes during pregnancy? 102
Hemodynamic assessment in patients with preterm premature rupture of the membranes (pPROM) 99
Maternal hemodynamics in early and late fetal growth restriction 94
ISUOG Consensus Statement on maternal hemodynamic assessment in hypertensive disorders of pregnancy and fetal growth restriction 94
Maternal hemodynamics for the identification of early fetal growth restriction in normotensive pregnancies 90
Umbilical venous flow and maternal hemodynamics as predictors of impaired fetal growth in gestational diabetes: a prospective study 89
C-peptide and insulin levels at 24-30 weeks' gestation: An increased risk of adverse pregnancy outcomes? 88
SARS-CoV-2, Endothelial Dysfunction, and the Renin-Angiotensin System (RAS): A Potentially Dangerous Triad for the Development of Pre-Eclampsia 87
G1. Maternal haemodynamics assessment in preterm delivery: two different haemodynamic profiles 84
Longitudinal maternal hemodynamic evaluation in uncomplicated twin pregnancies according to chorionicity: physiological cardiovascular dysfunction in monochorionic twin pregnancy 82
The impact of maternal cardiovascular status prior to labor on birth outcomes: an observational study 82
The cardiac-fetal-placental unit: fetal umbilical vein flow rate is linked to the maternal cardiac profile in fetal growth restriction 81
NO donors on top of anti-hypertensive therapy reduces complications in chronic hypertensive pregnancies with hypodynamic circulation 79
Maternal cardiac systolic and diastolic function: Relationship with uteroplacental resistances. A Doppler and echocardiographic longitudinal study 78
Low pregestational fat mass and subsequent maternal cardiovascular maladaptation in early pregnancy. The missing link for preeclampsia 75
Pre-eclampsia: One name, two conditions - The case for early and late disease being different 73
Computerized evaluation of fetal heart rate during tocolytic treatment: Comparison between atosiban and ritodrine 73
The role of umbilical vein blood flow assessment in the prediction of fetal growth velocity and adverse outcome: a prospective observational cohort study 73
F4. NO donors and haemodynamic changes in fetal growth restriction 73
Total vascular resistance and left ventricular morphology as screening tools for complications in pregnancy 70
Left ventricular concentric geometry as a risk factor in gestational hypertension 70
Intrauterine growth restriction and fetal body composition 66
L18. Total Vascular Resistance in complicated pregnancies 61
Nitric oxide donor increases umbilical vein blood flow and fetal oxygenation in fetal growth restriction: A pilot study 57
Maternal diastolic dysfunction and left ventricular geometry in gestational hypertension 57
Maternal diastolic function in asymptomatic pregnant women with bilateral notching of the uterine artery waveform at 24 weeks' gestation: A pilot study 54
Maternal cardiovascular haemodynamics in normal and complicated pregnancies 53
Postpartum cerebellar infarction and haemolysis, elevated liver enzymes, low platelet (HELLP) syndrome 51
Physical exercise improves cardiovascular function after preeclampsia and reduces the risk of recurrent preeclampsia in the subsequent pregnancy: an echocardiographic prospective cohort study 44
Hemodynamics‐guided treatment of hypertensive disorders of pregnancy: systematic review and meta‐analysis 35
The Cardiac-Fetal-Placental Unit: links between umbilical venous flow and maternal hemodynamics in fetal growth restriction 32
Individualized maternal positioning to optimize cardiac output and placental perfusion 32
null 4
null 3
Totale 14.134
Categoria #
all - tutte 41.829
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 41.829


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022205 0 0 0 0 12 10 17 13 14 38 24 77
2022/2023554 98 49 19 54 41 111 44 43 55 12 22 6
2023/2024208 18 2 4 8 8 60 12 7 4 10 2 73
2024/20252.041 17 184 100 45 14 335 259 115 190 112 384 286
2025/20263.360 226 136 352 361 334 174 356 456 311 262 235 157
2026/20271.544 381 133 533 472 25 0 0 0 0 0 0 0
Totale 14.134